header logo
Vallibel FD
vallible LE
Latest
Covaxin: India approves home-grown COVID vaccine for children
Covaxin: India approves home-grown COVID vaccine for children
Mobitel inner 1278

India’s Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group.

 

Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age in September and submitted the trial data to the Drugs and Comptroller General of India (DCGI) at the start of this month.

 

“After detailed deliberation, the committee recommended for grant of market authorization of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation,” the subject expert panel said in a statement.

 

The made-in-India vaccine will be administered in two doses, with a gap of 20 days between the first and second dose.

 

In a statement, Bharat Biotech said the clinical trial data it had submitted was thoroughly reviewed by the Central Drugs Standard Control Organisation (CDSCO) and SEC, who provided their positive recommendations.

 

“This represents one of the first approvals worldwide for Covid-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thank the DCGI, Subject Experts Committee, and CDSCO for their expedited review process. We now await further regulatory approvals from the CDSCO prior to product launch and market availability of Covaxin for children,” the vaccine developer said.

 

The emergency use authorisation, however, is subject to certain conditions. The developer of Covaxin will continue the study as per Whole Virion, Inactivated Corona Virus Vaccine the approved clinical trial protocol.

 

It will have to provide updated prescribing information/package Insert (PI), Summary of Product Characteristics (SmPC) and factsheet.

 

Moreover, the firm should submit safety data including the data on AEFI and AESI, with due analysis, every 15 days for the first two months and monthly thereafter and also as per requirement of New Drugs & Clinical Trials Rules, 2019, it said.

 

Meanwhile, the WHO is yet to grant emergency use authorisation to Covaxin. Bharat Biotech had reportedly submitted all documents required for the listing to the WHO by July 9, and the WHO review process, which takes close to six weeks, had commenced by July-end.

 

Back in August, India had also granted emergency use approval to ZyCov-D’s Covid-19 vaccine for children between the ages of 12 to 18. The vaccine is developed by pharmaceutical firm Zydus Cadila and is the first DNA vaccine to be approved in the world.

 

Source: India Today

 

 

 

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them (mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Comments

0
Comments are disabled

Note: Due to legal constraints, the Ada Derana Editorial team has taken a decision to disable comments on all articles concerning ongoing court procedures.

MostRead
Mobitel 1278
VideoStories
Can satellite data help improve disaster response? Senior Research Scientist at NASA explains

Can satellite data help improve disaster response? Senior Research Scientist at NASA explains

Bitumen shortage disrupts road development projects in Sri Lanka; RDA seeks alternative supplies

Bitumen shortage disrupts road development projects in Sri Lanka; RDA seeks alternative supplies

Minister urges govt workers engaged in trade union action to submit proposals to Salaries Commission

Minister urges govt workers engaged in trade union action to submit proposals to Salaries Commission

 Experts warn of significant rise in antibiotic resistance 40,000 non-physicians prescribing drugs?

Experts warn of significant rise in antibiotic resistance 40,000 non-physicians prescribing drugs?

Rajangane Saddharathana remanded over violent clashes in A’pura,  three other suspects granted bail

Rajangane Saddharathana remanded over violent clashes in A’pura, three other suspects granted bail

Appeals Court upholds four-year prison sentence  imposed on Ven. Gnanasara Thero

Appeals Court upholds four-year prison sentence imposed on Ven. Gnanasara Thero

Court suspends bail granted to Namal Rajapaksa Shashi Weerawansa’s two-year prison sentence upheld

Court suspends bail granted to Namal Rajapaksa Shashi Weerawansa’s two-year prison sentence upheld

 “I exposed corruption and not wronged” Trade union activist Ananda Palitha remanded until Nov. 25

“I exposed corruption and not wronged” Trade union activist Ananda Palitha remanded until Nov. 25

Trade union actions continue against 2027 Budget; Monday, declared a national day of protest

Trade union actions continue against 2027 Budget; Monday, declared a national day of protest

 Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

 Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

Sajith calls for stronger Sri Lanka-China ties;  Focus on innovation and sustainable economic growth

Sajith calls for stronger Sri Lanka-China ties; Focus on innovation and sustainable economic growth

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

Lassana Flora